US9320701B2 - Sun-care compositions - Google Patents
Sun-care compositions Download PDFInfo
- Publication number
- US9320701B2 US9320701B2 US13/388,688 US201013388688A US9320701B2 US 9320701 B2 US9320701 B2 US 9320701B2 US 201013388688 A US201013388688 A US 201013388688A US 9320701 B2 US9320701 B2 US 9320701B2
- Authority
- US
- United States
- Prior art keywords
- sun
- care
- composition
- composition according
- monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000000178 monomer Substances 0.000 claims abstract description 31
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229920001577 copolymer Polymers 0.000 claims abstract description 22
- 229920001897 terpolymer Polymers 0.000 claims abstract description 19
- 239000000516 sunscreening agent Substances 0.000 claims description 44
- 230000000475 sunscreen effect Effects 0.000 claims description 39
- 239000000243 solution Substances 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- -1 2-oxoborn-3-ylidene Chemical group 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000003981 vehicle Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 229920001296 polysiloxane Polymers 0.000 claims description 7
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 239000002569 water oil cream Substances 0.000 claims description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-M 4-aminobenzoate Chemical compound NC1=CC=C(C([O-])=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-M 0.000 claims description 5
- 230000002708 enhancing effect Effects 0.000 claims description 5
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 4
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- 229960000846 camphor Drugs 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 claims description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000004264 Petrolatum Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 3
- 229910000420 cerium oxide Inorganic materials 0.000 claims description 3
- DRVWBEJJZZTIGJ-UHFFFAOYSA-N cerium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Ce+3].[Ce+3] DRVWBEJJZZTIGJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- UOUJSJZBMCDAEU-UHFFFAOYSA-N chromium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Cr+3].[Cr+3] UOUJSJZBMCDAEU-UHFFFAOYSA-N 0.000 claims description 3
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical class [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 3
- 235000013980 iron oxide Nutrition 0.000 claims description 3
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 239000007764 o/w emulsion Substances 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 claims description 3
- 239000003002 pH adjusting agent Substances 0.000 claims description 3
- 235000019271 petrolatum Nutrition 0.000 claims description 3
- 229940066842 petrolatum Drugs 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 239000007762 w/o emulsion Substances 0.000 claims description 3
- 238000004078 waterproofing Methods 0.000 claims description 3
- 229910001928 zirconium oxide Inorganic materials 0.000 claims description 3
- BDACRXKSBPLSJG-UHFFFAOYSA-N (2-hydroxy-4-methoxyphenyl)-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O BDACRXKSBPLSJG-UHFFFAOYSA-N 0.000 claims description 2
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 claims description 2
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 claims description 2
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000007983 Tris buffer Substances 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 claims description 2
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 claims description 2
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 claims description 2
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 claims description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims description 2
- HUVYTMDMDZRHBN-UHFFFAOYSA-N drometrizole trisiloxane Chemical compound C[Si](C)(C)O[Si](C)(O[Si](C)(C)C)CC(C)CC1=CC(C)=CC(N2N=C3C=CC=CC3=N2)=C1O HUVYTMDMDZRHBN-UHFFFAOYSA-N 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- PVWXTVUZGJXFJQ-UHFFFAOYSA-N methyl 4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(C(C)C)=C(C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 claims description 2
- 125000006353 oxyethylene group Chemical group 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 claims description 2
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 claims description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000011787 zinc oxide Substances 0.000 claims 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical group CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 abstract description 16
- 229920000642 polymer Polymers 0.000 description 14
- 239000010408 film Substances 0.000 description 13
- 230000008901 benefit Effects 0.000 description 7
- 230000004224 protection Effects 0.000 description 7
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 235000010215 titanium dioxide Nutrition 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 3
- 229960005193 avobenzone Drugs 0.000 description 3
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 3
- 239000000264 sodium ferrocyanide Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- 206010063493 Premature ageing Diseases 0.000 description 2
- 208000032038 Premature aging Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229960004881 homosalate Drugs 0.000 description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 2
- 229940048848 lauryl glucoside Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- SDVOJIRXJLEGCY-ZFRLFKIJSA-N spc3 Chemical compound N([C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCCCC[C@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCCNC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCCNC(=O)[C@H](CCCCNC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)NC(=O)[C@H](CCCCNC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)CN)C(=O)NCCC(O)=O)C(=O)CNC(=O)[C@@H]1CCCN1C(=O)CN SDVOJIRXJLEGCY-ZFRLFKIJSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WMZHDICSCDKPFS-UHFFFAOYSA-N triacont-1-ene Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC=C WMZHDICSCDKPFS-UHFFFAOYSA-N 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 2
- KFYRJJBUHYILSO-YFKPBYRVSA-N (2s)-2-amino-3-dimethylarsanylsulfanyl-3-methylbutanoic acid Chemical compound C[As](C)SC(C)(C)[C@@H](N)C(O)=O KFYRJJBUHYILSO-YFKPBYRVSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 1
- WMJBVALTYVXGHW-UHFFFAOYSA-N 3,3-diphenylprop-2-enoic acid Chemical class C=1C=CC=CC=1C(=CC(=O)O)C1=CC=CC=C1 WMJBVALTYVXGHW-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- KHNVQXPXLJIGFS-UHFFFAOYSA-N 7-[(6-hydroxy-5-phenyl-2H-benzotriazol-4-yl)methyl]-6-phenyl-2H-benzotriazol-5-ol Chemical class C=1C=CC=CC=1C=1C(O)=CC=2NN=NC=2C=1CC(C=1N=NNC=1C=C1O)=C1C1=CC=CC=C1 KHNVQXPXLJIGFS-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000021559 Dicerandra Species 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004193 disodium 5'-ribonucleotide Substances 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present application relates to a sun-care composition having an SPF value of at least 15 comprising: (a) one or more sun-care actives; (b) a copolymer (or a terpolymer) containing (A) at least one vinyl pyrrolidone monomer and at least one vinyl caprolactam monomer or at least one vinyl acetate monomer or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer; and (c) a cosmetically/dermatologically acceptable vehicle.
- the sun-care actives include UV-A and/or UV-B sunscreens or mixtures thereof.
- the present application relates to sunscreen compositions that provide a boost in the SPF value of the composition and provide enhanced sensory properties when applied.
- the present application describes compositions that provide efficient photo protection and that can be applied in a smooth, continuous film over the skin which leaves the skin feeling soft and silky.
- UV radiation is part of the electromagnetic (light) spectrum that reaches the earth from the sun. It has wavelengths shorter than visible light, making it invisible to the naked eye. These wavelengths are classified as UVA, UVB, or UVC, with UVA the longest of the three at 320-400 nanometers (nm, or billionths of a meter). UVB ranges from 290 to 320 nm. With even shorter rays, most UVC is absorbed by the ozone layer and does not reach the earth.
- UV-A radiation which makes up 90% of solar radiation produces tanning of the skin.
- UV-A rays cause, in particular, a loss in the elasticity of the skin and the appearance of wrinkles, promoting a premature aging thereof.
- Sunscreen compositions are applied to the skin to protect the skin from the sun's ultraviolet rays.
- awareness of the detrimental effects of unprotected UV exposure has increased and, as a result, consumers are seeking higher levels of protection.
- the standards of the sunscreens have been raised by stringent testing requirements by Regulatory authorities.
- the most significant changes within these regulations are the new requirements for UVA protection and the added test for photostability of finished sunscreen formulations.
- SPF levels of at least 30, reaching upwards of 50+.
- high levels of UVA protection are required in order to make a UVA claim.
- sunscreen makers may include several different sunscreen ingredients.
- One of the most opted way of achieving higher SPF values, is to increase the amount of sunscreens in the product. This approach however will increase the cost of the product and might negatively impact the sensory characteristics of the product.
- Others have added small amounts of UV absorbers like butyl octyl salicylate as boosters to formulations. Others increased SPF by adding light scattering/refracting polymers to the product such as styrene/acrylates copolymers.
- U.S. Pat. No. 6,436,376 discloses a regime/regimen for improved UV-photoprotecting human skin, hair and/or scalp against the deleterious effects of ultraviolet irradiation, comprising topically applying thereon (a) an effective UV-photoprotecting amount of at least one UV-A and/or UV-B sunscreen and (b) an amount of the copolymer tricontanyl PVP (Ganex-WP-660).
- the compositions are said to be particularly effective for the sunscreen avobenzone.
- U.S. Pat. No. 6,436,377 claims a regime/regimen for improved UV-photoprotecting human skin, hair and/or scalp against the deleterious effects of ultraviolet irradiation, comprising applying thereon at least one UV-A and/or UV-B sunscreen and the interpolymer PVP/dimethiconylacrylate/polycarbamyl/polyglycol ester in an amount effective to significantly enhance the SPF value.
- U.S. Pat. No. 7,368,105 discloses photoprotective compositions comprising at least one dibenzoylmethane UV-screening agent, a stabilizing admixture comprising arylalkyl benzoate compound and at least one bis-resorcinyl triazine compound.
- U.S. Pat. No. 4,524,061 discloses polymeric sunscreen agents comprising interpolymers of (a) an olefinic p-aminobenzoate devoid of hydroxy substitution; (b) N-vinylpyrrolidone; (c) a monomer selected from the group consisting of a vinyl lactam having a number average molecular weight of at least 125, an acrylate or methacrylate or any mixture thereof and optionally (d) acrylic or methacrylic acid.
- U.S. Pat. No. 5,916,541 discloses a waterproof sunscreen and insect repellent stable emulsion composition
- a waterproof sunscreen and insect repellent stable emulsion composition comprising an emulsifying agent for forming a stable emulsion; and a film forming agent present in an amount effective to form a thin film when the composition is applied to the skin of a person and provides SPF factors of about 2 to about 50.
- Poly (vinyl pyrrolidone/1-triacontene) is specifically disclosed.
- a consumer consideration while purchasing a sunscreen product is how the product feels and how well it spreads over the skin.
- product feel could determine whether the consumer decides to purchase the product.
- U.S. Pat. No. 7,416,719 describes a sunscreen composition comprising: (a) at least one sunscreen agent; and (b) at least one lauryl glucoside emulsifier, wherein the lauryl glucoside emulsifier imparts an enhanced soft, silky feel to the composition.
- sunscreens formulated with the goal of inhibiting skin damage from the sun's rays.
- the sunscreen composition filters or blocks the harmful UV-A and UV-B rays that can damage and harm the skin.
- the present application discloses sun-care compositions with enhanced performance and aesthetics.
- the present application discloses sun-care compositions comprising one or more sun-care actives in combination with specific polymers derived from vinyl lactams.
- the compositions exhibit enhanced/elevated efficiency of the sunscreen active.
- the compositions of the invention provide the user with an enhanced soft, silky feel when applied to skin while still providing superior protection from damaging ultraviolet light.
- a sun-care composition comprising one or more sun-care actives in combination with specific polymers derived from vinyl lactams which are capable of enhancing/elevating the efficiency of the sunscreen.
- sun-care composition having an SPF value of at least 15 comprising:
- the sun-care active can be selected from the group consisting of UV-A sunscreens, UV-B sunscreens, physical sun blockers and combinations thereof.
- the sun-care composition of the present invention typically has an SPF of at least 15, more particularly about 25, and in certain cases from about 50 to about 130.
- the copolymer (or a terpolymer) containing at least one vinyl pyrrolidone monomer and at least one vinyl caprolactam monomer can be selected from the group consisting of vinyl pyrrolidone/vinyl caprolactam/dimethylaminoethylmethacrylate (DMAEMA) (available from ISP under the brand name of Advantage® S, Advantage® HC-37, Advantage® LC-E), vinyl pyrrolidone/vinyl caprolactam/dimethylaminopropylmethylacrylamide (DMAPMA) acrylate (available from ISP under the brand name of Aquaflex® SF-40), vinyl pyrrolidone/vinyl caprolactam/dimethylaminopropylmethylacrylamide acrylate/methacryloylaminopropyl lauryldimoniumchloride (available from ISP under the brand name of Aquastyle® 300) and vinyl pyrrolidone/vinyl caprolactam
- DMAEMA
- the copolymer containing at least one vinyl pyrrolidone monomer or at least one vinyl caprolactam monomer and at least one vinyl acetate monomer contains units derived from vinyl pyrrolidone and vinyl acetate present in a ratio from about 70:30 to about 30:70 (available from ISP under various brands PVP/VA-S-630, PVP/VA-735, PVP/VA-635, PVP/VA-535, PVP/VA-335).
- the one or more sun-care actives can be used in an amount from about 1 wt. % to about 50 wt. % of the total weight of the composition.
- the copolymer (or terpolymer) may be used from about 0.05 wt. % to about 10 wt. % of the total weight of the composition, more preferably, from about 0.5 wt. % to about 2 wt. % of the total weight of the composition.
- the pharmaceutically/cosmetically/dermatologically acceptable vehicle is well known to those skilled in the art and includes a cream, a lotion, an emulsion, an oil, a spray, a gel, a aerosol, an aqueous or hydra-alcoholic solution, a suspension, an anhydrous solution, a serum, an ointment, a gel, or a paste.
- the sun-care composition of the present invention can further comprise one or more additional components selected from the group consisting of skin-feel additives, moisturizing agents, film former/waterproofing agents, pH adjuster/chelating agents, emulsifiers, preservatives, anti-aging agents, skin whitening agents, exfoliating agents, treatment ingredients, fragrances and mixtures thereof.
- the sun-care composition in a preferred embodiment is in the form of an oil-in-water emulsion, a water-in-oil emulsion, an oil-water-oil emulsion, a water-oil-water emulsion, a water-in-silicone emulsion, an oily solution, a lipid fusion, a hydro-alcoholic gel, an anhydrous gel, an aqueous gel, an alcoholic solutions or a hydro-alcoholic solution.
- This invention also provides a method for enhancing the SPF-value of one or more sun-care actives in UV-photoprotecting sun-care compositions comprising admixing and intimately formulating the pharmaceutically/cosmetically/dermatologically acceptable carrier and a copolymer or terpolymer comprising (A) at least one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer in an amount effective to enhance the SPF value of said one or more sun-care actives.
- the present invention relates to a SPF enhanced sun-care composition
- a SPF enhanced sun-care composition comprising one or more sun-care actives, a copolymer (or a terpolymer) and a pharmaceutically/cosmetically/dermatologically acceptable vehicle.
- the copolymer (or a terpolymer) comprises (A) at least one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer.
- the sunscreen composition of the present invention is uniquely formulated to provide an elevated SPF and enhanced feeling of softness and silkiness when the sunscreen composition is applied to the skin. Moreover, the composition is capable of being easily and uniformly applied over the skin. These enhanced properties are achieved, in large part, by formulating the sunscreen composition as described herein.
- the one or more sun-care actives may be selected from the group consisting of UV-A sunscreens, UV-B sunscreens, physical sun blockers and combinations thereof.
- UV-A or UV-B sunscreens examples include p-aminobenzoic acid and its derivatives, anthranilates, benzophenones, camphor derivatives, cinnamic derivatives, dibenzoyl methanes, beta,beta-diphenylacrylate derivatives, salicylic derivatives, triazine derivatives, benzimidazole compounds, bis-benzoazolyl derivatives, methylene bis-(hydroxyphenylbenzotriazole) compounds, sunscreen polymers, silicones, and mixtures thereof.
- Examples of physical sun blockers include cerium oxides, chromium oxides, cobalt oxides, iron oxides, red petrolatum, silicone-treated titanium dioxides, titanium dioxides, zinc oxides, and/or zirconium oxides and mixtures thereof.
- the sun-care active can be selected from the group consisting of p-aminobenzoic acid, oxyethylene (25 mol) p-aminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, ethyl N-oxypropylene p-aminobenzoate, glycerol p-aminobenzoate, 4-isopropylbenzyl salicylate, 2-ethylhexyl 4-methoxycinnamate, methyl diisopropylcinnamate, isoamyl 4-methoxycinnamate, diethanolamine 4-methoxycinnamate, 3-(4′-trimethylammunium)-benzyliden-bornan-2-one methylsulfate, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfonate, 2,4-dihydroxybenzophenone, 2,2′,4,4′
- compositions will typically contain sun-care active in the range of about 1 wt. % to about 50 wt. % of the total weight of the composition.
- the amount of sunscreen agent in the composition will vary in the above range depending on the sun protection factor (SPF) desired. The higher the SPF, the greater the total amount of sunscreen agent used. In accordance with certain embodiments, the composition contains more than one sunscreen agent.
- SPF number used in connection with the present invention refers to the dose required to produce a minimal erythema on protected skin, divided by the dose required to produce the same degree of skin erythema without the product applied.
- the sun-care composition of the present invention should provide an SPF value of at least 15. More particularly, it should provide an SPF of at least 25 and in another particular embodiment of the invention provides an SPF of from about 50 to about 130.
- copolymer or a terpolymer used in connection with the present invention refers to polymers/copolymers/terpolymers of vinyl pyrrolidones, capable of enhancing the SPF value to at least 15 and more particularly from about 50 to about 130 and also forming a uniform smooth continuous film over the skin surface to provide complete protection.
- the copolymer (or a terpolymer) comprising at least one vinyl pyrrolidone monomer and at least one vinyl caprolactam monomer is selected from the group consisting of vinyl pyrrolidone/vinyl caprolactam/dimethylaminoethylmethacrylate (DMAEMA) (available from ISP under the brand name of Advantage® S, Advantage® HC-37, Advantage® LC-E), vinyl pyrrolidone/vinyl caprolactam/dimethylaminopropylmethylacrylamide (DMAPMA) (available from ISP under the brand name of Aquaflex® SF-40), vinyl pyrrolidone/vinyl caprolactam/dimethylaminopropylmethylacrylamide(DMAPA)/methacryloylaminopropyl lauryldimoniumchloride (available from ISP under the brand name of Aquastyle® 300).
- DMAEMA vinyl pyrrolidone/vinyl caprolactam/dimethyl
- the copolymer (or a terpolymer) comprises at least one vinyl pyrrolidone monomer and at least one vinyl acetate monomer present in a weight ratio from about 70:30 to about 30:70 (available from ISP under various brands such as PVP/VA-S-630, PVP/VA-735, PVP/VA-635, PVP/VA-535, PVP/VA-335).
- Molecular weights for some specific examples are provided below:
- the copolymer or terpolymer comprises at least one vinyl caprolactam monomer and at least one vinyl acetate monomer.
- the amount of copolymer (or terpolymer) in the present invention typically ranges from about 0.05 wt. % to about 10 wt. % of the total weight of the composition. More particularly it may range from about 0.5 wt. % to about 2 wt. % of the total weight of the composition.
- molecular weight of the polymer is not believed to be critical to the practice of this invention, good results have been achieved using polymers having a molecular weight from about 5,000 to100,000, and more particularly from about 10,000-65,000.
- Molecular weight in g/mol may be based on weight average molecular weight determined by methods, such as light scattering, known to those of ordinary skill in the art.
- Examples of pharmaceutically/cosmetically/dermatologically acceptable vehicles include a cream, a lotion, an emulsion, an oil, a spray, a gel, a aerosol, an aqueous or hydra-alcoholic solution, a suspension, an anhydrous solution, a powder, a serum, an ointment, a gel, or a paste.
- the amount of cosmetically acceptable vehicle in the present composition will vary considerably based upon product form, but typically will range from about 30 wt % to about 99.95 wt % and preferably about 50 wt % to about 99 wt %, based upon the total weight of the composition.
- the sun-care composition further comprises one or more additional components selected from the group consisting of skin-feel additives, moisturizing agents film former/waterproofing agents, pH adjuster/chelating agents, emulsifiers, preservatives, anti-aging agents, skin whitening agents, exfoliating agents, treatment ingredients, fragrances and mixtures thereof.
- composition can be made into any suitable product form.
- product forms include, but are not limited to, an aerosol, balm, cream, gel, lotion, mousse, patch, pomade, pump spray, roll-on, solution, stick or towelette.
- the present composition may be formulated in the form of an emulsion.
- the emulsion may be, for example, anhydrous, an oil-in-water emulsion, a water-in-oil emulsion, an oil-water-oil emulsion, a water-oil-water emulsion, a water-in-silicone emulsion, an oily solution, a lipid fusion, a hydro-alcoholic gel, an anhydrous gel, an aqueous gel, an alcoholic solutions or a hydro-alcoholic solution.
- the sunscreen compositions may be prepared by using techniques and methods well known in the art. In general, ingredients are incorporated by mixing and applying heat if necessary, until the composition is uniform and homogeneous. The composition may be homogenized to ensure homogeneity and to build the proper viscosity. The sunscreen compositions of the present invention typically are then packaged in any package or container suitable for a sunscreen composition.
- a method for enhancing the SPF-value of one or more sun-care actives in UV-photoprotecting sun-care compositions comprising admixing and intimately formulating the pharmaceutically/cosmetically/dermatologically acceptable carrier and a copolymer (terpolymer) comprising at least (A) one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer in an amount effective to enhance the SPF value of said one or more sun-care actives or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer.
- terpolymer comprising at least (A) one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer in an amount effective to enhance the SPF value of said one or more sun-care actives or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate
- the sunscreen composition of the present invention is uniquely formulated to provide an enhanced feeling of softness and silkiness when the sunscreen composition is applied to the skin. Moreover, the composition is capable of being easily and uniformly applied over the skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
- (a) one or more sun-care actives;
- (b) a copolymer (or a terpolymer) containing the residue of (A) at least one vinyl pyrrolidone monomer and (i) at least one vinyl caprolactam monomer or (ii) at least one vinyl acetate monomer or (B) at least one vinyl caprolactam monomer and at least one vinyl acetate monomer; and
- (c) a pharmaceutically/cosmetically/dermatologically acceptable vehicle.
Polymer | Typical Molecular Weight | ||
E335 | 28,800 | ||
E535 | 36,700 | ||
E635 | 38,200 | ||
E735 | 56,700 | ||
I335 | 12,700 | ||
I535 | 19,500 | ||
I735 | 22,300 | ||
INCI Name |
77-1 | 79-4 | 141-1 | 77-2 | 145-2 | 145-4 | 148-7 | 148-6 | 145-5 | 145-6 | |
A | B | C | D | E | F | G | H | I | J | |
Avobenzone | 2.0 | 2.0 | 2.0 | 3.0 | 3.00 | 3.00 | 2.0 | 2.0 | 2.0 | 2.0 |
Homosalate | 7.0 | 7.0 | 7.0 | 8.0 | 8.00 | 8.00 | 7.0 | 7.0 | 7.0 | 7.0 |
Octisalate | 5.0 | 5.0 | 5.0 | 4.0 | 4.00 | 4.00 | 5.0 | 5.0 | 5.0 | 5.0 |
Octinoxate | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | 7.5 | |||
Benzophenone-3 | 3.0 | 3.0 | 3.0 | 5.0 | 5.00 | 5.00 | 3.00 | 3.0 | 3.0 | 3.0 |
Octocrylene | 2.35 | 2.35 | 2.35 | |||||||
Aquaflex | 1.5 | 0.5 | 1.5 | |||||||
SF-40 | ||||||||||
Advantage S | 0.5 | 0.5 | 0.5 | |||||||
PVP/VA | 1.0 | |||||||||
E535 | ||||||||||
PVP/VA | 1.0 | 1.00 | ||||||||
S630 | ||||||||||
PVP/VA | 1.00 | |||||||||
E735 | ||||||||||
Ethanol | QS | QS | QS | QS | QS | QS | QS | QS | QS | QS |
Percent | N/A | 43.16 | 74.9 | N/A | 24.05 | 30.84 | 45.67 | 26.34 | 57.18 | 47.5 |
Boost | ||||||||||
INCI Name |
60-2 | 60-1 | 95-2 | 10-2 | 141-2 | 95-1 | 142-4 | |
K | L | M | N | O | P | Q | |
Phase A | |||||||
Deionized water | QS | QS | QS | QS | QS | QS | QS |
Disodium EDTA | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
Glycerin | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Acrylates/C10-30 alkyl | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 |
acrylate crosspolymer | |||||||
Phase B | |||||||
Sodium lauryl lactylate (and) | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 |
Cetearyl alcohol (and) | |||||||
glyceryl Stearate | |||||||
Behenyl alcohol | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.5 | 0.50 |
Ceteareth 20 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 | 3.50 |
Diisopropyl adipate | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
Avobenzone | 3.00 | 2.00 | 2.00 | 3.00 | 2.00 | 2.00 | 3.00 |
Homosalate | 8.00 | 7.00 | 7.00 | 8.00 | 7.00 | 7.00 | 8.00 |
Octisalate | 4.00 | 5.00 | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 |
Octinoxate | 7.50 | 7.50 | 7.50 | 7.50 | |||
Benzophenone-3 | 5.00 | 3.00 | 3.00 | 5.00 | 3.00 | 3.00 | 5.00 |
Octocrylene | 2.35 | 2.35 | 2.35 | ||||
Aquaflex SF-40 | 0.50 | 1.50 | 0.50 | ||||
Advantage S | 0.50 | 0.50 | 0.50 | ||||
PVP/VA E535 | |||||||
PVP/VA S630 | 1.00 | ||||||
PVP/VA E735 | 1.00 | ||||||
Phase C | |||||||
Triethanolamine | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
Propylene glycol (and) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
diazolidinyl urea (and) | |||||||
methylparaben (and) | |||||||
propylparaben | |||||||
Percent Boost | N/A | N/A | 24.66 | 25.51 | 34.11 | 39.70 | 43.49 |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/388,688 US9320701B2 (en) | 2009-08-06 | 2010-08-05 | Sun-care compositions |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23185509P | 2009-08-06 | 2009-08-06 | |
PCT/US2010/044500 WO2011017491A1 (en) | 2009-08-06 | 2010-08-05 | Sun-care compositions |
US13/388,688 US9320701B2 (en) | 2009-08-06 | 2010-08-05 | Sun-care compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
US20120219515A1 US20120219515A1 (en) | 2012-08-30 |
US9320701B2 true US9320701B2 (en) | 2016-04-26 |
Family
ID=43544656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/388,688 Active US9320701B2 (en) | 2009-08-06 | 2010-08-05 | Sun-care compositions |
Country Status (2)
Country | Link |
---|---|
US (1) | US9320701B2 (en) |
WO (1) | WO2011017491A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012078961A1 (en) * | 2010-12-10 | 2012-06-14 | Isp Investment Ins. | Compositions comprising stabilized keto-enol uv absorbers |
WO2018175836A1 (en) * | 2017-03-23 | 2018-09-27 | Isp Investments Llc | Skin care compositions comprising a terpolymer, process for preparing the same and method of use thereof |
BR112021010118B1 (en) * | 2018-12-06 | 2023-12-19 | Colgate-Palmolive Company | PERSONAL CARE COMPOSITIONS AND USE THEREOF |
US12083199B2 (en) | 2019-09-10 | 2024-09-10 | LCS Advanced Solutions, LLC | Mineral, anhydrous, broad-spectrum sunscreen |
EP4353328A3 (en) | 2022-10-15 | 2024-05-22 | LCS Advanced Solutions, LLC | Structurally diverse, stable, and radiation-protective particle matrix sunscreen and cosmetic compositions and related methods |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4524061A (en) * | 1983-04-22 | 1985-06-18 | Gaf Corporation | Polymeric sunscreens |
US5641480A (en) * | 1994-12-08 | 1997-06-24 | Lever Brothers Company, Division Of Conopco, Inc. | Hair care compositions comprising heteroatom containing alkyl aldonamide compounds |
US5916541A (en) | 1992-06-25 | 1999-06-29 | Stewart; Ernest G. | Water resistant sunscreen and insect repellent composition |
US6284227B1 (en) | 1992-06-25 | 2001-09-04 | Iguana, Llc | Water resistant sunscreen and insect repellent composition |
US6436377B1 (en) | 2001-02-26 | 2002-08-20 | Societe L'oreal S.A. | Enhanced SPF sunscreen (sprayable) formulations comprising interpolymers of PVP/dimethiconylacrylate/polycarbamyl/polyglycol ester |
US6436376B1 (en) | 2001-02-26 | 2002-08-20 | Societe L'oreal S.A. | Enhanced SPF UV-sunscreen/tricontanyl PVP photoprotecting (sprayable) formulations |
US20050079141A1 (en) | 2001-12-09 | 2005-04-14 | Lars Zander | Cosmetic and/or pharmaceutical sunscreen preparations |
US20050186160A1 (en) | 2000-07-07 | 2005-08-25 | Aust Duncan T. | Sunscreen composition with enhanced SPF and water resistant properties |
US20060013839A1 (en) | 2004-07-15 | 2006-01-19 | L'oreal | Shine-enhancing film formers |
US20060110346A1 (en) | 2004-11-04 | 2006-05-25 | L'oreal | Transfer-resistant cosmetic compositions |
US20060233726A1 (en) * | 2005-04-18 | 2006-10-19 | Nia Sam D C | SPF scalp sun screen protector |
US7368105B2 (en) | 2004-07-02 | 2008-05-06 | L'oreal | Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate/bis-resorcinyl triazine compounds and photoprotective compositions comprised thereof |
US7416719B2 (en) | 2001-09-21 | 2008-08-26 | Playtex Products, Inc. | Sunscreen compositions |
US20080317795A1 (en) | 2007-05-21 | 2008-12-25 | Daniel Henry Traynor | Highly charged microcapsules |
-
2010
- 2010-08-05 US US13/388,688 patent/US9320701B2/en active Active
- 2010-08-05 WO PCT/US2010/044500 patent/WO2011017491A1/en active Application Filing
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4524061A (en) * | 1983-04-22 | 1985-06-18 | Gaf Corporation | Polymeric sunscreens |
US5916541A (en) | 1992-06-25 | 1999-06-29 | Stewart; Ernest G. | Water resistant sunscreen and insect repellent composition |
US6284227B1 (en) | 1992-06-25 | 2001-09-04 | Iguana, Llc | Water resistant sunscreen and insect repellent composition |
US5641480A (en) * | 1994-12-08 | 1997-06-24 | Lever Brothers Company, Division Of Conopco, Inc. | Hair care compositions comprising heteroatom containing alkyl aldonamide compounds |
US20050186160A1 (en) | 2000-07-07 | 2005-08-25 | Aust Duncan T. | Sunscreen composition with enhanced SPF and water resistant properties |
US6436377B1 (en) | 2001-02-26 | 2002-08-20 | Societe L'oreal S.A. | Enhanced SPF sunscreen (sprayable) formulations comprising interpolymers of PVP/dimethiconylacrylate/polycarbamyl/polyglycol ester |
US6436376B1 (en) | 2001-02-26 | 2002-08-20 | Societe L'oreal S.A. | Enhanced SPF UV-sunscreen/tricontanyl PVP photoprotecting (sprayable) formulations |
US7416719B2 (en) | 2001-09-21 | 2008-08-26 | Playtex Products, Inc. | Sunscreen compositions |
US20050079141A1 (en) | 2001-12-09 | 2005-04-14 | Lars Zander | Cosmetic and/or pharmaceutical sunscreen preparations |
US7368105B2 (en) | 2004-07-02 | 2008-05-06 | L'oreal | Photostabilization of dibenzoylmethane UV-screening agents with arylalkyl benzoate/bis-resorcinyl triazine compounds and photoprotective compositions comprised thereof |
US20060013839A1 (en) | 2004-07-15 | 2006-01-19 | L'oreal | Shine-enhancing film formers |
US20060110346A1 (en) | 2004-11-04 | 2006-05-25 | L'oreal | Transfer-resistant cosmetic compositions |
US20060233726A1 (en) * | 2005-04-18 | 2006-10-19 | Nia Sam D C | SPF scalp sun screen protector |
US20080317795A1 (en) | 2007-05-21 | 2008-12-25 | Daniel Henry Traynor | Highly charged microcapsules |
Non-Patent Citations (1)
Title |
---|
PCT, International Search Report, International Application No. PCT/US2010/044500 (mailed Sep. 17, 2010, published Feb. 10, 2011). |
Also Published As
Publication number | Publication date |
---|---|
US20120219515A1 (en) | 2012-08-30 |
WO2011017491A1 (en) | 2011-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003237369B2 (en) | Sunscreen compositions | |
ES2269040T3 (en) | PHOTOSTABLE COSMETIC PREPARATIONS THAT FILTER THE LIGHT. | |
AU2009215013B2 (en) | Photoprotective compositions with glycol and styrene/acrylate copolymer | |
US20120015016A1 (en) | UV Protecting Composition And Methods Of Use | |
US7014842B2 (en) | Sunscreen composition | |
US10617627B2 (en) | Robust sunscreen compositions | |
US6436376B1 (en) | Enhanced SPF UV-sunscreen/tricontanyl PVP photoprotecting (sprayable) formulations | |
US9320701B2 (en) | Sun-care compositions | |
US9855448B2 (en) | Sun-care compositions | |
US20080247976A1 (en) | Sunscreen and personal care compositions comprising a random terpolymer | |
JP5814265B2 (en) | Self-adaptive polymers for anhydrous sun protection formulations | |
US6436377B1 (en) | Enhanced SPF sunscreen (sprayable) formulations comprising interpolymers of PVP/dimethiconylacrylate/polycarbamyl/polyglycol ester | |
CN105120831B (en) | Sunscreen composition comprising fatty acid and non-ionic linear polymer | |
CA2989120C (en) | Solubilizing agents for functional uv active compounds | |
US20240374492A1 (en) | A sunscreen composition comprising avobenzone and a method for photostabilization | |
DE102004029327A1 (en) | Gel, useful in hair styling, comprises transparent or translucent gel aqueous phase (comprising polyacrylate thickener and/or cellulose derivative thickener, fixative, polymer film formers); and emulsion droplet in the aqueous phase | |
AU2013200692A1 (en) | Photoprotective Compositions with Glycol and Styrene/Acrylate Copolymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE BANK OF NOVA SCOTIA, CANADA Free format text: SECURITY AGREEMENT;ASSIGNORS:HERCULES INCORPORATED;ISP INVESTMENTS INC.;REEL/FRAME:027810/0519 Effective date: 20120227 |
|
AS | Assignment |
Owner name: ISP INVESTMENTS INC., DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BARRETT, CHRISTINE M.;ROSS, TRACEY;GUERRERO, RITAMARIE;AND OTHERS;SIGNING DATES FROM 20120210 TO 20120413;REEL/FRAME:028157/0553 |
|
AS | Assignment |
Owner name: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC, OHIO Free format text: RELEASE OF PATENT SECURITY AGREEMENT;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:030025/0320 Effective date: 20130314 Owner name: AQUALON COMPANY, DELAWARE Free format text: RELEASE OF PATENT SECURITY AGREEMENT;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:030025/0320 Effective date: 20130314 Owner name: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC, O Free format text: RELEASE OF PATENT SECURITY AGREEMENT;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:030025/0320 Effective date: 20130314 Owner name: ISP INVESTMENTS INC., DELAWARE Free format text: RELEASE OF PATENT SECURITY AGREEMENT;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:030025/0320 Effective date: 20130314 Owner name: HERCULES INCORPORATED, DELAWARE Free format text: RELEASE OF PATENT SECURITY AGREEMENT;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:030025/0320 Effective date: 20130314 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: ISP INVESTMENTS LLC, DELAWARE Free format text: CONVERSION;ASSIGNOR:ISP INVESTMENTS INC.;REEL/FRAME:041556/0499 Effective date: 20160818 |
|
AS | Assignment |
Owner name: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT, CANADA Free format text: SECURITY AGREEMENT;ASSIGNORS:AVOCA, INC.;HERCULES LLC;ISP INVESTMENTS LLC;AND OTHERS;REEL/FRAME:043084/0753 Effective date: 20170630 Owner name: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT, Free format text: SECURITY AGREEMENT;ASSIGNORS:AVOCA, INC.;HERCULES LLC;ISP INVESTMENTS LLC;AND OTHERS;REEL/FRAME:043084/0753 Effective date: 20170630 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
AS | Assignment |
Owner name: PHARMACHEM LABORATORIES LLC, NEW JERSEY Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:051557/0504 Effective date: 20200110 Owner name: HERCULES LLC, DELAWARE Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:051557/0504 Effective date: 20200110 Owner name: AVOCA LLC, NORTH CAROLINA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:051557/0504 Effective date: 20200110 Owner name: ISP INVESTMENTS LLC, NEW JERSEY Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:THE BANK OF NOVA SCOTIA;REEL/FRAME:051557/0504 Effective date: 20200110 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |